Cite
APA Citation
Cosnes, J., Sokol, H., Bourrier, A., Nion‐Larmurier, I., Wisniewski, A., Landman, C., Marteau, P., Beaugerie, L., Perez, K., & Seksik, P. (2016). adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease. Alimentary pharmacology & therapeutics, 44(10), 1102–1113. http://access.bl.uk/ark:/81055/vdc_100038571166.0x000051